MedPath

A diagnosis of fatty liver using controlled attenuation parameter (CAP) loading Fibroscan and a comparative analysis with clinical data

Not Applicable
Recruiting
Conditions
Abnormality of liver function
Registration Number
JPRN-UMIN000013046
Lead Sponsor
Tokai University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
530
Inclusion Criteria

Not provided

Exclusion Criteria

the patient who did not get the informed consent for this study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CAP score(the evaluation of liver fat content:Fibroscan)
Secondary Outcome Measures
NameTimeMethod
iver stiffness(Fibroscan),physical parameters, blood biochemical values and ultrasound scanning.
© Copyright 2025. All Rights Reserved by MedPath